...
首页> 外文期刊>Canadian Medical Association Journal: Journal de l'Association Medicale Canadienne >Analgesia for skin-breaking procedures in newborns and children: what works best?
【24h】

Analgesia for skin-breaking procedures in newborns and children: what works best?

机译:在新生儿和儿童中进行皮肤破损手术的镇痛药:什么最有效?

获取原文
获取原文并翻译 | 示例

摘要

Healthy newborns routinely experience acute pain during blood sampling for metabolic screening, injection of vitamin K or hepatitis vaccine, or circumcision. Children are similarly exposed to acute pain due to vaccination, invasive procedures or trauma. Acute pain caused by skin-breaking procedures can lead to physiologic instability and behavioural distress, and it has downstream effects on subsequent pain processing, development and stress respon-sivity. Because of these detrimental effects, reduction or prevention of pain are worthy clinical goals that are also expected by most parents.Opioids, such as fentanyl and morphine, form the mainstay of pediatric pain management, but they may not be effective against injury-induced acute pain in newborns or children. Accumulating data suggest that opioids lead to harmful side effects, tolerance and possibly altered brain development. Other analgesic and anesthetic agents also appear to increase brain cell death in animal studies, fuelling concerns about their use, particularly in newborns. Such concerns have led to the development of nonpharmacologic therapies such as sucrose, massage and kangaroo care for neonatal pain, and distraction techniques, hypnosis and cognitive-behavioural interventions for pediatric pain.
机译:健康的新生儿通常会在血液样本进行代谢筛查,注射维生素K或肝炎疫苗或进行包皮环切手术时经历剧烈疼痛。同样,儿童由于疫苗接种,侵入性手术或外伤而遭受急性疼痛。破坏皮肤的程序所引起的急性疼痛可能导致生理不稳定和行为困扰,并且对后续的疼痛处理,发展和应激反应具有下游影响。由于这些不利影响,减轻或预防疼痛是大多数父母也应达到的临床目标。阿片类药物(例如芬太尼和吗啡)形成了小儿疼痛管理的主体,但它们可能无法有效预防由伤害引起的急性新生儿或儿童疼痛。越来越多的数据表明,阿片类药物会导致有害的副作用,耐受性并可能改变大脑发育。在动物研究中,其他镇痛剂和麻醉剂也似乎增加了脑细胞死亡,加剧了人们对其使用的担忧,尤其是在新生儿中。这种担忧导致了非药物疗法的发展,例如蔗糖,按摩和袋鼠对新生儿疼痛的护理,以及分散技术,催眠和儿科疼痛的认知行为干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号